Repos Pharma Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

Repos Pharma General Information

Description

Operator of a drug research and development company designed to provide treatment for cancer. The company's platform provides re-profiling drugs for treating additional forms of cancer, enabling cancer patients to begin their treatment and get a successful treatment for cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • Bredgrand 14
  • 753 20 Uppsala
  • Sweden
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Repos Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Startup
To view Repos Pharma’s complete valuation and funding history, request access »

Repos Pharma Executive Team (1)

Name Title Board Seat Contact Info
Sven Mårten Fryknäs Co-Founder & Chief Executive Officer
To view Repos Pharma’s complete executive team members history, request access »

Repos Pharma Board Members (1)

Name Representing Role Since
Angelica Loskog Nxt2b Chairman 000 0000
To view Repos Pharma’s complete board members history, request access »

Repos Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Nxt2b Venture Capital Minority 000 0000 000000 0
To view Repos Pharma’s complete investors history, request access »